Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
DocuSign Fiscal Q2 Adjusted Earnings, Revenue Rise; Guides for Q3

DocuSign Fiscal Q2 Adjusted Earnings, Revenue Rise; Guides for Q3

MT newswireMT newswire2026/09/03 20:15
04:15 PM EDT, 09/03/2026 (MT Newswires) -- DocuSign (DOCU) reported fiscal Q2 non-GAAP net income late Thursday of $1.16 per diluted share, up from $0.92 a year earlier. Analysts polled by FactSet expected $1.09. Revenue in the three months ended July 31 rose to $875.7 million from $800.6 million a year earlier. Analysts expected $867.2 million. DocuSign expects Q3 revenue of $886 million to $890 million. Analysts project $888.5 million. The company expects full-year revenue of $3.50 billion to $3.51 billion, compared to previous guidance of $3.49 billion to $3.502 billion. Analysts project $3.50 billion.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

After Eli Lilly's nearly 300% surge in four years, Wall Street remains bullish: The "hidden pipeline" beyond GLP-1 is underestimated

Eli Lilly’s share price has surged nearly 300% since the approval of its first GLP-1 drug, with its market capitalization surpassing 1 trillion USD, yet Wall Street remains optimistic about its continued growth. Berenberg has upgraded Eli Lilly’s rating to “Buy," believing that Mounjaro and Zepbound will continue to see strong volume, and that the oral GLP-1 drug could further drive demand. Additionally, Eli Lilly continues to expand into areas such as cancer and sleep disorders, and the potential of its non-obesity-related pipelines remains underestimated by the market.

华尔街见闻2026/09/18 13:21

Goldman Sachs: The industrial sector is "even more expensive" than tech stocks; global sector pricing logic is changing

The 12-month forward price-to-earnings ratio of the industrial sector has now surpassed that of the technology sector, indicating that the relative valuations among various sectors in global stock markets are undergoing a shift.

智通财经2026/09/18 13:11